- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02572102
Impact of Energy Drinks and Panax Ginseng on Heart Rhythm
October 7, 2015 updated by: University of the Pacific
Impact of Energy Drinks and Panax Ginseng on Heart Rhythm in Healthy Volunteers
To assess the cardiac effects of an energy drink and Panax Ginseng in healthy volunteers.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Energy drinks are composed of a variety of ingredients such as caffeine, taurine, and panax ginseng amongst others.
The safety and efficacy of these ingredients individually and in combination need further exploration.
This study is designed to assess the electrocardiographic and blood pressure effects of energy drinks and panax ginseng in healthy volunteers.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy male or female adults 18-40 years old.
Exclusion Criteria:
- Baseline corrected QT (QTc) interval greater than 440 milliseconds,
- blood pressure at initial screening appointment greater than 140/90 mmHg,
- concurrent use of prescriptions or OTC medications taken on a daily basis,
- pregnant females,
- patients with any baseline ECG abnormalities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Energy Drink
Two 16 ounce containers of an Energy Drink
|
Energy Drink, two 16oz containers consumed in 45 minutes
|
Active Comparator: Panax Ginseng
800 mg of Panax Ginseng in 70 mL of cherry syrup, 20 mL of lime juice, 410 mL of carbonated water
|
Panax Ginseng, lime juice, water and cherry flavoring
|
Placebo Comparator: Placebo
70 mL of cherry syrup, 20 mL of lime juice, 410 mL of carbonated water
|
Lime juice, water and cherry flavoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
QTc interval changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
Systolic blood pressure changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
QT interval changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
PR interval changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
QRS duration changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
Heart rate changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
Diastolic blood pressure changes
Time Frame: 5.5 hours over 3 visits
|
5.5 hours over 3 visits
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Anticipated)
March 1, 2016
Study Completion (Anticipated)
March 1, 2016
Study Registration Dates
First Submitted
October 6, 2015
First Submitted That Met QC Criteria
October 7, 2015
First Posted (Estimate)
October 8, 2015
Study Record Updates
Last Update Posted (Estimate)
October 8, 2015
Last Update Submitted That Met QC Criteria
October 7, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 15-119
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
RadiRad Co., Ltd.Hualien Tzu Chi General HospitalNot yet recruitingBlood Pressure
-
Riphah International UniversityRecruiting
-
GE HealthcareNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruiting
Clinical Trials on Energy Drink
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
University of the PacificCompletedBlood Pressure | Electrical Alternation of HeartUnited States
-
Université de MontréalUnknown
-
Karolinska InstitutetRegion Stockholm; Research department, Ersta HospitalTerminated
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States
-
Utrecht Institute for Pharmaceutical SciencesRed Bull GmbHCompleted